SCHEMBL657047

SCHEMBL657047

O=C(C=Cc1ccc(Cl)cc1)c1ccccn1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.77
KDM4E B2RXH2 4/20 0.77
NPC1 O15118 3/20 0.77
PKM P14618 3/20 0.77
RAB9A P51151 3/20 0.77
LMNA P02545 2/20 0.77
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
ALDH1A1 P00352 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
MAOB P27338 2/20 0.64
PLIN1 O60240 1/20 0.58
MAPK1 P28482 1/20 0.58
PLIN5 Q00G26 1/20 0.58
ABHD5 Q8WTS1 1/20 0.58
KRAS P01116 1/20 0.56
CYP1B1 Q16678 1/20 0.55
MAOA P21397 1/20 0.55
GRM5 P41594 1/20 0.53
CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31088345 1.00 MAPT (0.77) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL657046 1.00 MAPT (0.77) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL12257967 0.92 MAPT (0.90) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL4400320 0.87 MAPT (1.00) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL977480 0.87 MAPT (1.00) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL31436352 0.86 MAPT (0.79) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL1604280 0.86 MAPT (0.79) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL9231011 0.84 MAPT (0.77) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL11973097 0.84 MAPT (0.77) MAPTKDM4ENPC1PKMRAB9A
SCHEMBL6793176 0.84 RAB9A (0.77) MAPTKDM4ENPC1PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed
EP-0677293-A1 PHARMACEUTICAL USE OF TERPYRIDINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1995-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB MAPT 964/4885KDM4E 1893/4885NPC1 2687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.